Nucleic Acid Therapeutics
The Corona pandemic has initiated a new phase in the field of vaccine development with the generation of RNA-based vaccines. But not only there: therapeutics developed on the basis of nucleic acids will play an increasingly important role in drug development or therapy in the coming years and change medicine. For untreatable or poorly treatable diseases, the new class of substances will show breakthrough treatment successes.
The CAS Research Focus brings together researchers to discuss the current state of development in the different research branches of nucleic acid-based therapeutics, as well as potential alternatives, and to explore new approaches.
- Vortrag mit Prof. Dr. Hans-Georg Rammensee – "On the Development of Personalized Cancer Vaccines Based on HLA Ligandome Analysis"
(19. Januar 2022, 19:00 Uhr) | (Wintersemester 2022/23)